Capital Impact Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-24,167
| Closed | -$772K | – | 238 |
|
|
2022
Q2 | $772K | Sell |
24,167
-4,834
| -17% | -$154K | 0.71% | 29 |
|
|
2022
Q1 | $1.01M | Buy |
29,001
+6,540
| +29% | +$227K | 0.73% | 36 |
|
|
2021
Q4 | $657K | Buy |
+22,461
| New | +$657K | 0.45% | 69 |
|
|
2020
Q4 | – | Sell |
-26,362
| Closed | -$1.45M | – | 127 |
|
|
2020
Q3 | $1.45M | Sell |
26,362
-5,000
| -16% | -$276K | 0.43% | 92 |
|
|
2020
Q2 | $1.98M | Sell |
31,362
-18,268
| -37% | -$1.15M | 0.66% | 74 |
|
|
2020
Q1 | $2.54M | Buy |
49,630
+1,475
| +3% | +$75.4K | 1.07% | 27 |
|
|
2019
Q4 | $3.83M | Hold |
48,155
| – | – | 1.35% | 13 |
|
|
2019
Q3 | $2.37M | Buy |
48,155
+8,289
| +21% | +$409K | 0.9% | 23 |
|
|
2019
Q2 | $2.15M | Sell |
39,866
-11,686
| -23% | -$631K | 0.79% | 41 |
|
|
2019
Q1 | $2.06M | Hold |
51,552
| – | – | 0.91% | 27 |
|
|
2018
Q4 | $2.06M | Hold |
51,552
| – | – | 0.88% | 28 |
|
|
2018
Q3 | $1.97M | Buy |
51,552
+3,017
| +6% | +$115K | 0.67% | 67 |
|
|
2018
Q2 | $2.3M | Buy |
48,535
+18,966
| +64% | +$900K | 0.85% | 29 |
|
|
2018
Q1 | $1.43M | Buy |
+29,569
| New | +$1.43M | 0.59% | 86 |
|